Diffusion tensor and volumetric magnetic resonance measures as biomarkers of brain damage in a small animal model of HIV

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lentz, Margaret R ^a   Peterson, Kristin L ^a   Ibrahim, Wael G ^a   Lee, Dianne E ^a   Sarlls, Joelle ^b   Lizak, Martin J ^c   Maric, Dragan ^c   Reid, William C ^a   Hammoud, Dima A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN SIZE; BRAIN VENTRICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DIFFUSION; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; JUVENILE ANIMAL; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBER; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; VOLUMETRIC MAGNETIC RESONANCE IMAGING; ANIMAL; BRAIN INJURY; DISEASE MODEL; FISCHER 344 RAT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NEUROIMAGING; PATHOLOGY; TRANSGENIC RAT;

BIOLOGICAL MARKER;

ANIMALS; BIOMARKERS; BRAIN INJURIES; CORPUS CALLOSUM; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; NEUROIMAGING; RATS; RATS, INBRED F344; RATS, TRANSGENIC;

EID: 84931000655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105752     Document Type: Article

References (58)

1. Alfahad TB, Nath A (2013) Update on HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep 13: 387.
2. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250.
3. Kaul M, Lipton SA (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4: 307-318. (Pubitemid 44027720)
4. Filippi M, Mastronardo G, Bastianello S, Rocca MA, Rovaris M, et al. (1998) A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis. J Neurol Sci 159: 94-101. (Pubitemid 28365890)
5. Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, et al. (2009) Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol 15: 324-333.
6. Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W (2001) Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 22: 277-283. (Pubitemid 32163456)
7. Chen Y, An H, Zhu H, Stone T, Smith JK, et al. (2009) White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV + patients. Neuroimage 47: 1154-1162.
8. Basser PJ (1995) Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8: 333-344.
9. Basser PJ, Mattiello J, LeBihan D (1994) Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103: 247-254.
10. Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66: 259-267. (Pubitemid 24016507)
11. Alexander AL, Lee JE, Lazar M, Field AS (2007) Diffusion tensor imaging of the brain. Neurotherapeutics 4: 316-329. (Pubitemid 46962420)
12. Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 15: 456-467. (Pubitemid 36054509)
13. Lerner A, Mogensen MA, Kim PE, Shiroishi MS, Hwang DH, et al. (2013) Clinical Applications of Diffusion Tensor Imaging. World Neurosurg.
14. Sullivan EV, Rohlfing T, Pfefferbaum A (2010) Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Dev Neuropsychol 35: 233-256.
15. Pierpaoli C, Basser PJ (1996) Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 36: 893-906. (Pubitemid 26396817)
16. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996) Diffusion tensor MR imaging of the human brain. Radiology 201: 637-648.
17. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, et al. (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436. (Pubitemid 35333862)
18. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, et al. (2005) Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140. (Pubitemid 40602893)
19. Tyszka JM, Readhead C, Bearer EL, Pautler RG, Jacobs RE (2006) Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. Neuroimage 29: 1058-1065. (Pubitemid 43184170)
20. Harsan LA, Poulet P, Guignard B, Steibel J, Parizel N, et al. (2006) Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res 83: 392-402. (Pubitemid 43184403)
21. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, et al. (2006) Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55: 302-308. (Pubitemid 43238098)
22. Naganawa S, Sato K, Katagiri T, Mimura T, Ishigaki T (2003) Regional ADC values of the normal brain: differences due to age, gender, and laterality. Eur Radiol 13: 6-11. (Pubitemid 36790485)
23. Pfefferbaum A, Adalsteinsson E, Sullivan EV (2005) Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging. Neuroimage 26: 891-899. (Pubitemid 40825031)
24. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, et al. (1993) Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43: 2099-2104. (Pubitemid 23318887)
25. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, et al. (1998) Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 55: 161-168.
26. Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, et al. (2011) Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol 17: 248-257.
27. Ragin AB, Storey P, Cohen BA, Epstein LG, Edelman RR (2004) Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol 25: 195-200. (Pubitemid 38235295)
28. Thurnher MM, Castillo M, Stadler A, Rieger A, Schmid B, et al. (2005) Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am J Neuroradiol 26: 2275-2281.
29. Wu Y, Storey P, Cohen BA, Epstein LG, Edelman RR, et al. (2006) Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 27: 656-660. (Pubitemid 44897794)
30. Peng J, Vigorito M, Liu X, Zhou D, Wu X, et al. (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218: 94-101.
31. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Jr., et al. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98: 9271-9276. (Pubitemid 32743906)
32. Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15: 14-24.
33. Ye F, Saunders R, Merkle H, Leopold D. A Strategy to enhance tissue contrast in the MDEFT sequence at high magnetic field; 2005; Toronto, Ontario, Canada. 830.
34. Calabrese E, Badea A, Watson C, Johnson GA (2013) A quantitative magnetic resonance histology atlas of postnatal rat brain development with regional estimates of growth and variability. Neuroimage 71: 196-206.
35. Pierpaoli C, Walker L, MO I, Barnett A, Chang L, et al. TORTOISE: an integrated software package for processing of diffusion MRI data; 2010; Stockholm, Sweden.
36. Paxinos G, Watson C (2007) The Rat Brain in Stereotaxic Coordinates. London: Academic Press.
37. Agrawal L, Louboutin JP, Reyes BA, Van Bockstaele EJ, Strayer DS (2012) HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol Dis 45: 657-670.
38. Bemelmans AP, Husson I, Jaquet M, Mallet J, Kosofsky BE, et al. (2006) Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J Neurosci Res 83: 50-60. (Pubitemid 43062009)
39. Carty ML, Wixey JA, Colditz PB, Buller KM (2008) Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci 26: 477-485.
40. Louboutin JP, Agrawal L, Reyes BA, Van Bockstaele EJ, Strayer DS (2007) Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther 14: 1650-1661. (Pubitemid 350143190)
41. Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, et al. (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33: 2228-2236. (Pubitemid 351992085)
42. Ratai EM, Bombardier JP, Joo CG, Annamalai L, Burdo TH, et al. (2010) Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS One 5: e10523.
43. Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, et al. (2007) A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 69: 1314-1321. (Pubitemid 47482445)
44. Meulendyke KA, Pletnikov MV, Engle EL, Tarwater PM, Graham DR, et al. (2012) Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease. J Neuroimmune Pharmacol 7: 454-464.
45. Li MD, Cao J, Wang S, Wang J, Sarkar S, et al. (2013) Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One 8: e59582.
46. Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, et al. (2013) Disrupted cerebral metabolite levels and lower nadir CD4+ counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage (Amst) 3: 132-142.
47. Wright PW, Heaps JM, Shimony JS, Thomas JB, Ances BM (2012) The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS 26: 1501-1508.
48. Chang L, Wong V, Nakama H, Watters M, Ramones D, et al. (2008) Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol 3: 265-274.
49. Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, et al. (2009) Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS 23: 1977-1985.
50. Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, et al. (2007) HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr 46: 564-573. (Pubitemid 350191049)
51. Davis SW, Dennis NA, Buchler NG, White LE, Madden DJ, et al. (2009) Assessing the effects of age on long white matter tracts using diffusion tensor tractography. Neuroimage 46: 530-541.
52. Bieniasz PD, Cullen BR (2000) Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol 74: 9868-9877.
53. Moran LM, Aksenov MY, Booze RM, Webb KM, Mactutus CF (2012) Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res 10: 415-424.
54. Moran LM, Booze RM, Mactutus CF (2013) Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat. J Neuroimmune Pharmacol 8: 988-997.
55. Mori S, Zhang J (2006) Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51: 527-539. (Pubitemid 44301829)
56. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, et al. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42: 963-972. (Pubitemid 28008427)
57. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P (1994) Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol 88: 538-544. (Pubitemid 24364701)
58. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, et al. (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25: 123-133. (Pubitemid 29221762)